A Neuron-specific Methyl-histone Regulatory Complex
A Neuron-specific Methyl-histone Regulatory Complex
批准号:
10401853
负责人:
Shigeki Iwase
金额:
$48.22万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-06-01 至 2025-04-30
关键词:
AT-Hook MotifsAddressAdoptedAffectAffinityAlternative SplicingBindingBiochemistryBrainCancer cell lineCatalytic DomainCellsCellular biologyChromatinChromatin Remodeling FactorChromatin StructureComplementComplexCryoelectron MicroscopyDNADNA BindingDNA SequenceDataDefectDevelopmentDiseaseEnzymesExcitatory SynapseExonsGene ExpressionGenetic TranscriptionGenomic approachGoalsHigher Order Chromatin StructureHistone H3HistonesHumanHuman GeneticsImpairmentIn VitroIntellectual functioning disabilityInvestigationKDM1A geneKnock-outKnowledgeLeadLysineMediatingMediator of activation proteinMissense MutationModelingMusMutateNeurodevelopmental DisorderNeuronsNucleosomesNucleotidesOrganPHD FingerPathogenesisPathologicPatientsPattern RecognitionPlayProtein IsoformsPublishingRNA SplicingReactionReaderRegulationReportingResearchRoleSubstrate SpecificityTestingautism spectrum disordercell typechromatin modificationdemethylationdesignembryonic stem cellexperimental studyfunctional genomicshistone demethylasehistone methylationhistone modificationin vivoinsightinterdisciplinary approachmouse modelneurodevelopmentnovel strategiesprotein protein interactionreconstitutionrecruitstructural biologysynaptogenesistherapeutic targettranscription factortranscriptome
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
It is widely accepted that cell-type-specific gene expression is primarily achieved by cell-type-specific
presence of transcription factors (TFs), which bind to cognate DNA sequences. TFs then initiate changes in
higher-order chromatin structures by recruiting chromatin modifiers, including histone-modifying enzymes.
Unlike TFs, chromatin modifiers tend to be ubiquitously expressed. Among the plethora of chromatin
modifications, regulators of histone methylation are more frequently mutated in neurodevelopmental disorders
(NDDs) such as intellectual disabilities (IDs) and autism. Why is the brain so sensitive to dysregulation of
histone methylation? Is methyl-histone regulation in neurons unique? Investigation of a limited number of cell
types, cancer-cell lines, and embryonic stem cells has hampered our ability to address these questions.
The overarching goal of my research group is to contribute to the understanding of how methyl-histone
regulations underlie normal and pathological brain functions. Our focus is on the LSD1-PHF21A histone-
demethylation complex, which involves neuron-specific alternative splicing. LSD1 is a histone demethylase for
histone H3 lysine 4 (H3K4me). PHF21A was the first-discovered “zero reader,” which recognizes unmethylated
H3K4 (H3K4me0), the reaction product of canonical LSD1 (LSD1-c). Both LSD1 and PHF21A
haploinsufficiencies lead to NDDs, suggesting their importance in brain development. The neuronal LSD1
isoform (LSD1-n), which carries an alternative exon in its catalytic domain, was reported to have distinct
substrate specificity. However, the specific lysine(s) targeted by LSD1-n remains controversial. The goal of this
proposal is to determine the roles of the neuronal LSD1-PHF21A complex. Our preliminary study showed that
PHF21A also carries an alternative exon right upstream of the H3K4me0-recognizing PHD finger. This region
of PHF21A contains an AT-hook motif, which directly binds to DNA; we found that the alternative exon disrupts
the AT-hook, hence the DNA binding, but not H3K4me0 binding. These observations raise an exciting
possibility that the neuronal PHF21A isoform (PHF21A-n) recognizes nucleosomes in a distinct manner
compared to canonical PHF21A (PHF21A-c), thereby cooperating with LSD1-n to generate the neuronal
transcriptome for normal brain development.
We propose testing the hypothesis using multidisciplinary approaches encompassing cell biology,
biochemistry, and structural biology. The research plan was developed to provide both mechanistic insights
into the regulation of histone modifications and a better understanding of the pathogenesis of
neurodevelopment disorders, which could lead to novel approaches for brain-specific therapeutic targets.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Neuronal Activity-dependent Pomoter Usage
-
批准号:10451349
-
项目类别:
-
资助金额:$22.88万
-
财政年份:2022
-
负责人:Shigeki Iwase
-
依托单位:
Neuronal Activity-dependent Pomoter Usage
-
批准号:10591519
-
项目类别:
-
资助金额:$18.95万
-
财政年份:2022
-
负责人:Shigeki Iwase
-
依托单位:
Diurnal Experimental Models to Investigate Neural Mechanisms of Sleep Disturbance in Smith-Magenis Syndrome
-
批准号:10359869
-
项目类别:
-
资助金额:$44.37万
-
财政年份:2021
-
负责人:Shigeki Iwase
-
依托单位:
A Neuron-specific Methyl-histone Regulatory Complex
-
批准号:10615745
-
项目类别:
-
资助金额:$48.22万
-
财政年份:2020
-
负责人:Shigeki Iwase
-
依托单位:
Neutralizing epigenomes in neurodevelopmental disorders
-
批准号:9266842
-
项目类别:
-
资助金额:$33.09万
-
财政年份:2015
-
负责人:Shigeki Iwase
-
依托单位:
Neutralizing epigenomes in neurodevelopmental disorders
-
批准号:9085410
-
项目类别:
-
资助金额:$32.71万
-
财政年份:2015
-
负责人:Shigeki Iwase
-
依托单位:
Neutralizing epigenomes in neurodevelopmental disorders
-
批准号:8964042
-
项目类别:
-
资助金额:$32.74万
-
财政年份:2015
-
负责人:Shigeki Iwase
-
依托单位:
Neutralizing epigenomes in neurodevelopment disorders
-
批准号:9233642
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2015
-
负责人:Shigeki Iwase
-
依托单位:
海外基金